![[Dehydro-Pro4] Substance P (4-11)](https://file.medchemexpress.com/product_pic/hy-p3820.gif "Click to View [Dehydro-Pro4] Substance P (4-11) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
dehydrodimers
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "dehydrodimers" in MCE Product Catalog:
10
10 Cited Publications
Cat. No.: HY-D0844
CAS No.: 27025-41-8
Synonyms: L-Glutathione oxidized; GSSG; Oxiglutatione
Cat. No.: HY-P3820
Target:
Research Areas:
Cat. No.: HY-P3223A
Target:
Research Areas:
Cat. No.: HY-P3223
CAS No.: 126872-95-5
Target:
Research Areas:
Cat. No.: HY-N15603
CAS No.: 261778-30-7
Synonyms: β-O-4 Dehydrodimer
Category:
Broussonetia papyrifera (Linnaeus) L'Heritier ex Ventenat Extract Plant Larix kaempferi (Lamb.) Carrière Extract Moraceae Extract Lignans Phenols Polyphenols Phenylpropanoids Pinaceae Extract
Target:
Cat. No.: HY-P12110
Target:
Research Areas:
Cat. No.: HY-P12338
Target:
Mitochondrial Metabolism STAT Reactive Oxygen Species (ROS) Amino Acid Derivatives Drug Derivative
Research Areas:
HNSS peptide is a chimeric hybrid peptide composed of the neuroprotective peptide S14G-Humanin and the mitochondria-targeted antioxidant peptide SS31. HNSS peptide is readily cleared in vivo and can be combined with nanocarriers to improve its stability. HNSS can be delivered via the FGFR1-targeting nanocarrier FGL-NP (Cit), ameliorating mitochondrial dysfunction, Aβ deposition, tau hyperphosphorylation, and cholinergic neuronal damage, and alleviating memory deficits in Alzheimer's disease mice. HNSS peptide is applicable for Alzheimer's disease-related research .
Cat. No.: HY-P12219
Synonyms: OP449
Research Areas:
COG449 (OP449) is a cell-penetrating peptide that binds to SET, prevents the formation of the SET-PP2A complex, and restores PP2A phosphatase activity. COG449 decreases the phosphorylation levels of AKT 308, ERK1/2, NFkB p65, and c-MYC S62, and reduces c-MYC stability and target gene expression. COG449 induces apoptosis, autophagy, and histone H3 hyperacetylation, and decreases the levels of SET, CIP2A, SETBP1, and Mcl-1. COG449 reduces cancer cell viability and decreases tumor mass in xenograft models. COG449 can be used for research on various cancers such as oral squamous cell carcinoma, T-cell acute lymphoblastic leukemia, B-CLL, non-Hodgkin lymphoma, and breast cancer .
Cat. No.: HY-P11882
CAS No.: 947545-69-9
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
